Eli Lilly and Company News Headlines

LLY 
$63.78
*  
0.59
0.92%
Get LLY Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare Shares Slightly Higher in Pre-Market; Vanda Pharmaceuticals Down 11% on Sustained Decline
6/19/2013 8:11:33 AM - MT Newswires

Sector Update: Healthcare
6/19/2013 8:10:25 AM - MT Newswires

CryoPort's Game-Changer In Frozen Biological Shipping
6/18/2013 12:54:00 PM - Seeking Alpha

FDA Probes 2 Deaths Possibly Related to Lilly Drug
6/18/2013 12:35:00 PM - Fox Business

Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
6/18/2013 8:01:00 AM - Seeking Alpha

Consumer Staples Leading Canadian Market Higher; Transition Therapeutics Jumps After Lilly Makes Milestone Payment
6/17/2013 2:18:43 PM - MT Newswires

Good News For This Small-Cap Biotech: Eli Lilly Wants To Develop Its Diabetes Drug
6/17/2013 11:00:00 AM - Seeking Alpha

Eli Lilly's Alzheimer's Beta-Secretase Inhibitor Hits The Skids
6/14/2013 6:22:00 PM - Seeking Alpha

Positive Data on Incyte/LLY's Baricitinib - Analyst Blog
6/14/2013 12:30:47 PM - Zacks.com

Lilly Alzheimer's Study Terminated - Analyst Blog
6/14/2013 11:30:01 AM - Zacks.com

Alkermes Changing The Standard Of Care For Schizophrenia
6/13/2013 4:06:00 PM - Seeking Alpha

Warning: This Might Be The Most Overvalued Sector In The Market
6/12/2013 11:00:00 AM - StreetAuthority

When It Comes To Biotech, Diversity Is Key
6/12/2013 7:51:00 AM - Seeking Alpha

CHMP Positive on Sanofi's Lantus - Analyst Blog
6/11/2013 6:13:01 PM - Zacks.com

Warning: The Rebound May Be Over For Big Pharma
6/11/2013 4:42:00 PM - Seeking Alpha

Apricus' Vitaros Approved in Europe - Analyst Blog
6/11/2013 4:28:54 PM - Zacks.com

Interest Rates Up Round 1 - Sorting Through The Data
6/7/2013 2:19:00 PM - Seeking Alpha

Bristol-Myers Squibb: The Untold Story Of Led Zeppelin
6/6/2013 8:11:00 AM - Seeking Alpha

Eli Lilly's Alimta Disappoints - Analyst Blog
6/4/2013 3:28:11 PM - Zacks.com

The Long Case For United Therapeutics
6/4/2013 10:37:00 AM - Seeking Alpha

The Dope On A Forest Labs Takeover
6/4/2013 8:32:00 AM - Seeking Alpha

Johnson & Johnson - Avoid This Safety Stock
6/2/2013 4:14:00 PM - Seeking Alpha

Patent Challenge from Perrigo - Analyst Blog
5/31/2013 6:28:00 PM - Zacks.com

Encouraging Data from Alkermes - Analyst Blog
5/29/2013 5:27:08 PM - Zacks.com

Stock Upgrades: Can Merck Lead the Dow to Another Terrific Tuesday?
5/28/2013 9:21:00 AM - Minyanville